NCT04518579View on ClinicalTrials.gov

Epidural-inhalational Versus Epidural-intravenous Anaesthesia on Anti-tumor Immunity in Patients With Cancer Colon

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

June 1, 2020

Study Completion Date

August 1, 2020

Conditions
Immunity Factors in Cancer Colon Patients
Interventions
PROCEDURE

thoracic epidural

undergo insertion of an epidural catheter, between T9 and T11 in patients undergoing left-sided resections and between T8 and T10 in patients undergoing right-sided resections

Trial Locations (1)

71511

South Egypt Cancer Institute, Asyut

All Listed Sponsors
lead

South Egypt Cancer Institute

OTHER

NCT04518579 - Epidural-inhalational Versus Epidural-intravenous Anaesthesia on Anti-tumor Immunity in Patients With Cancer Colon | Biotech Hunter | Biotech Hunter